Thanks Marco,Some whinge and moan, other seek answers. So I/we...

First 1007 Last

Share
Profile

Follow
MusCabout

495 Posts.

149

19/06/24

12:36

Post #: 74388470
Share

Originally posted by Apuesta: ↑

I wrote an E-Mail to Joe and ask him for an Update....this is what he wrote back to me:

Hi Marco,

Thank you for your email.

As per public statements third party due diligence continues under the Jefferies strategic partner process and we also have ongoing constructive engagement for partnering/finance with the public sector. All associated discussions and negotiations are bound by confidentiality. Yes, I understand how the lack of visibility on these processes is frustrating but it is the same for all businesses at this stage of project development.

What we can say, is that the strategic partner process with Jefferies is being broadened to again consider Chinese offtake and partial funding for the development of the Karibib part of the project to initially produce just a concentrate – see recent quarterly reports. US policy has become clearer since the beginning of the year for this and it is evident that DFC funding can still be secured with offtake going to China, as the US recognises that some supply chains such as lithium will continue to rely on China for many years to come. We just need to be cognisant of the US position on Foreign Entity Of Concern (FEOC).

As outlined in the prospectus, with further cost cutting measures that have been implemented Lepidico is forecast to have cash into CY2025. We also have the ability to place the shortfall under the prospectus until early August. The market is currently under pressure till month end due to tax loss selling, which should then abate. Placing the shortfall would provide cash through most of CY2025.

We will update the market as and when finance milestones are reached.

Your support as a shareholder is greatly appreciated and I can assure you that management is committed to the Phase 1 Project becoming a reality.

Kind regards,

Joe

Joe Walsh

Managing Director

Lepidico Ltd

Expand

Thanks Marco,

Some whinge and moan, other seek answers. So I/we thank you for doing so and sharing with us.

LPD Price at posting: 0.3¢ Sentiment: Hold Disclosure: Held
22 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 209 more messages in this thread...

First 1007 Last

Add LPD (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $25.76M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
79	61705458	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	72204154	43

View Market Depth

No.	Vol.	Price($)
79	61705458	0.002
92	211106960	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	72204154	43
0.004	37214082	45
0.005	13550066	15
0.006	3150999	8
0.007	2277188	7

Last trade - 10.33am 04/10/2024 (20 minute delay)

LPD (ASX) Chart

Day chart unavailable

Thanks Marco,Some whinge and moan, other seek answers. So I/we...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Marco,Some whinge and moan, other seek answers. So I/we...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News